PHARMAGEN, INC. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
PHARMAGEN, INC. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $2.23 million as of 2012-09-30, per its 10-Q filed 2012-11-14.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2012-11-14
- 2012-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $2.23M.
- 2012-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $1.19M.
- 2011-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$244.37K.
- 2011-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$221.39K.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2012-09-30 | $2.23M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $1.19M 10-Q/A · filed 2012-09-14 |
| 2011-12-31 | -$244.37K 10-Q · filed 2012-02-13 |
| 2011-09-30 | -$221.39K 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$198.39K 10-Q · filed 2012-02-13 |